Nurses as adverse drug reaction reporting advocates

Jan Schjøtt; Trond R Pettersen; Lillan Mo Andreassen; Tormod K Bjånes

doi:10.1093/eurjcn/zvac113

Nurses as adverse drug reaction reporting advocates

Eur J Cardiovasc Nurs. 2023 Dec 14;22(8):765-768. doi: 10.1093/eurjcn/zvac113.

Authors

Jan Schjøtt^{1

2

3}, Trond R Pettersen^{3

4}, Lillan Mo Andreassen^{1

2}, Tormod K Bjånes²

Affiliations

¹ Regional Medicines Information and Pharmacovigilance Centre (RELIS Vest), Haukeland University Hospital, Jonas Lies vei 91B, 5021 Bergen, Norway.
² Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.
³ Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
⁴ Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.

PMID: 36453029
DOI: 10.1093/eurjcn/zvac113

Abstract

Adverse drug reactions (ADRs) is a challenge in modern healthcare, particularly given the increasing complexity of drug therapy, an ageing population, rising multimorbidity, and a high patient turnover. The core activity of detecting potential ADRs over the last half century has been spontaneous reporting systems. A recent Norwegian regulation commits healthcare professionals other than physicians and dentists to report serious ADRs. In this discussion paper, we share our preliminary experience with a training programme using nurses as ADR advocates to stimulate ADR reporting among the clinical staff in a hospital department.

Keywords: Adverse drug reactions; Cardiovascular drugs; Nurses; Pharmacovigilance; Training programme.

MeSH terms

Adverse Drug Reaction Reporting Systems
Drug-Related Side Effects and Adverse Reactions*
Health Personnel
Humans
Pharmacovigilance
Physicians*